Skip to main content
by SciGen® Technologies S.A. All rights reserved.
HOPA 14th Annual Conference 2018
March 21 - 24, 2018 Denver, Convention Center and Hyatt Regency
Posters by ID
Posters by Title
Randomized, Placebo-Controlled Trial of FOND (fosaprepitant, ondansetron, dexamethasone) Versus FOND+O (FOND plus olanzapine) for the Prevention of Chemotherapy Induced Nausea and Vomiting in Hematology Patients Receiving Highly Emetogenic Chemotherapy...
AU Medical Center
Give it 1/5
Give it 2/5
Give it 3/5
Give it 4/5
Give it 5/5
No votes yet
Copyright © 2015-2018,
SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.
Enter Poster ID (e.gGoNextPreviousCurrent